小笠原 壽恵
Department School of Medicine(Tokyo Women's Medical University Adachi Medical Center), School of Medicine Position Assistant Professor |
|
Language | Japanese |
Title | JAK-2 negative acute monocytic leukemia developed in essential thrombocythemia with JAK2 mutation |
Conference | The 79th Annual Meeting of the Japanese Society of Hematology |
Promoters | The Japanese Journal of Clinical Hematology |
Conference Type | Nationwide Conferences |
Presentation Type | Poster notice |
Lecture Type | General |
Publisher and common publisher | Dept.Med. Gastroenterology and Hematology, Unveiled.of Miyazaki
Kotaro Shida, Kazuya Shimoda |
Date | 2017/10/20 |
Venue (city and name of the country) |
Japan, Tokyo |
Society abstract | 臨床血液 58(9),556 2017 |
Summary | Essential thrombocythemia (ET) is an indolent myeloproliferative neoplasm (MPN) with a transformation to acute myeloid leukemia in less than 5 % of patients, which usually occurs as acute megakaryoblastic leukemia. We report a JAK2-positive ET patient who developed acute monocytic leukemia, whose clone revealed no JAK2 mutation.
79-year-old man was diagnosed JAK2-positive ET in 2008 and treated with hydroxycarbamide. He complained general fatigue in 2015. His laboratory test revealed WBC of 50 x109 /L with 41% monocytic cells. Bone marrow examination showed hypercellular marrow with 81% monoblasts and promonocytes. Leukemia cells showed positivity for non-specific esterase activity and CD13 and CD36. Cytogenetic analysis of bone marrow cells revealed additional aberrantions of 8 and TET2 but JAK2V617F mutation. He was diagnosed acute monoblastic and monocytic leukemia. Although we did not have the chance to evaluate TET2 mutation in JAK2-mutated cells at the time of ET diagnosis, we speculate that TET2 mutation occurred in MPN initiating cells and was associated with development of JAK2-mutated MPN.The absence of JAK2 mutation in the leukemia cells in this case suggests an emergence of leukemia from the clone distinct from JAK2-negative MPN cells carrying TET2 mutation. The mechanism of leukemic transformation of ET should be explored by detailed genetic analysis in similar cases. |